CAY10597 is primarily utilized in research settings as a selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). This enzyme plays a significant role in the metabolism of epoxyeicosatrienoic acids (EETs), which are involved in various physiological processes, including inflammation, blood pressure regulation, and pain management. By inhibiting sEH, CAY10597 helps to increase the levels of EETs, thereby potentially offering therapeutic benefits in conditions such as hypertension, chronic pain, and inflammatory diseases. Its application is particularly valuable in preclinical studies aimed at understanding the biological pathways and therapeutic potential of sEH inhibition in various disease models.